Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Treatment of cocaine cardiovascular toxicity: a systematic review

Abstract

INTRODUCTION: Cocaine abuse is a major worldwide health problem. Patients with acute cocaine toxicity presenting to the emergency department may require urgent treatment for tachycardia, dysrhythmia, hypertension, and coronary vasospasm, leading to pathological sequelae such as acute coronary syndrome, stroke, and death. OBJECTIVE: The objective of this study is to review the current evidence for pharmacological treatment of cardiovascular toxicity resulting from cocaine abuse. METHODS: MEDLINE, PsycINFO, Database of Abstracts of Reviews of Effects (DARE), OpenGrey, Google Scholar, and the Cochrane Library were searched from inception to November 2015. Articles on pharmacological treatment involving human subjects and cocaine were selected and reviewed. Evidence was graded using Oxford Centre for Evidence-Based Medicine guidelines. Treatment recommendations were compared to current American College of Cardiology/American Heart Association guidelines. Special attention was given to adverse drug events or treatment failure. The search resulted in 2376 articles with 120 eligible involving 2358 human subjects. Benzodiazepines and other GABA-active agents: There were five high-quality (CEBM Level I/II) studies, three retrospective (Level III), and 25 case series/reports (Level IV/V) supporting the use of benzodiazepines and other GABA-active agents in 234 subjects with eight treatment failures. Benzodiazepines may not always effectively mitigate tachycardia, hypertension, and vasospasm from cocaine toxicity. Calcium channel blockers: There were seven Level I/II, one Level III, and seven Level IV/V studies involving 107 subjects and one treatment failure. Calcium channel blockers may decrease hypertension and coronary vasospasm, but not necessarily tachycardia. Nitric oxide-mediated vasodilators: There were six Level I/II, one Level III, and 25 Level IV/V studies conducted in 246 subjects with 11 treatment failures and two adverse drug events. Nitroglycerin may lead to severe hypotension and reflex tachycardia. Alpha-adrenoceptor blocking drugs: There were two Level I studies and three case reports. Alpha-1 blockers may improve hypertension and vasospasm, but not tachycardia, although evidence is limited. Alpha-2-adrenoceptor agonists: There were two high-quality studies and one case report detailing the successful use of dexmedetomidine. Beta-blockers and β/α-blockers: There were nine Level I/II, seven Level III, and 34 Level IV/V studies of β-blockers, with 1744 subjects, seven adverse drug events, and three treatment failures. No adverse events were reported for use of combined β/α-blockers such as labetalol and carvedilol, which were effective in attenuating both hypertension and tachycardia. Antipsychotics: Seven Level I/II studies, three Level III studies, and seven Level IV/V case series and reports involving 168 subjects have been published. Antipsychotics may improve agitation and psychosis, but with inconsistent reduction in tachycardia and hypertension and risk of extrapyramidal adverse effects. Other agents: There was only one high level study of morphine, which reversed cocaine-induced coronary vasoconstriction but increased heart rate. Other agents reviewed included lidocaine, sodium bicarbonate, amiodarone, procainamide, propofol, intravenous lipid emulsion, propofol, and ketamine. CONCLUSIONS: High-quality evidence for pharmacological treatment of cocaine cardiovascular toxicity is limited but can guide acute management of associated tachycardia, dysrhythmia, hypertension, and coronary vasospasm. Future randomized prospective trials are needed to evaluate new agents and further define optimal treatment of cocaine-toxic patients.

Overview

Integrity signals

Registry

Crossref · 10.3109/15563650.2016.1142090

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 151 references

Research works printed but not linked: 12

  1. Lombard J, 1988, West J Med, 148, 466
  2. Ní Chróinín D, 2012, Ir Med J, 105, 118
  3. Rollingher IM, 1986, CMAJ, 135, 45
  4. Coleman DL, 1982, West J Med, 136, 444
  5. Rummel TS., 1989, J Tenn Med Assoc, 82, 541
  6. Stenberg RG, 1989, Arch Pathol Lab Med, 113, 521
  7. Grewal RP, 1991, Acta Neurol (Napoli), 13, 279
  8. Martinez-Quintana E, 2013, Int J Endocrinol Metab, 11, 48
  9. Burton KR, 1989, J Clin Psychiatry, 50, 305
  10. Williams RG, 1996, Can J Cardiol, 12, 1295
  11. Cox RD, 2004, Vet Hum Toxicol, 46, 21
  12. Grigorov V, 2004, Cardiovasc J S Afr, 15, 139

Cited by

See all 116

Metadata

Authors
Richards, J. R., Garber, D., Laurin, E. G., Albertson, T. E., Derlet, R. W., Amsterdam, E. A., Olson, K. R., Ramoska, E. A., & Lange, R. A.
Affiliations
  • University of California Davis Medical Center (US)
  • University of California, San Francisco (US)
  • Drexel University (US)
  • Texas Tech University Health Sciences Center (US)
Corresponding author
Richards, John R.
Venue
Clinical Toxicology
Published
2016-02-26
Volume
54
Issue
5
Pages
345-364
ISSN
  • 0009-9309 (ISSN-L)
  • 1556-3650
  • 1556-9519
OpenAlex
W2288746277
Cited by
116
References
151
Citations by year
2026: 9 · 2025: 4 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 17 · 2020: 14 · 2019: 10 · 2018: 10 · 2017: 12 · 2016: 9
FWCI
3.11
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
cocaine abuse, pharmacotherapy, benzodiazepines, calcium channel blockers, nitroglycerin, alpha-1 adrenergic blockers, dexmedetomidine, beta-blockers, tachycardia, hypertension, coronary vasospasm, acute coronary syndrome, stroke, treatment failure, adverse drug reactions, emergency department management, ACC/AHA guidelines
MeSH terms
Benzodiazepines, Calcium Channel Blockers, Cardiovascular System, Cocaine, Heart Rate, Humans, Hypertension, Nitric Oxide, Tachycardia, Vasodilator Agents, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Cocaine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of cocaine cardiovascular toxicity: a systematic review. https://app.cochat.ai/papers/10.3109/15563650.2016.1142090
The paper
Richards, J. R., Garber, D., Laurin, E. G., Albertson, T. E., Derlet, R. W., Amsterdam, E. A., Olson, K. R., Ramoska, E. A., & Lange, R. A. (2016). Treatment of cocaine cardiovascular toxicity: a systematic review. Clinical Toxicology. https://doi.org/10.3109/15563650.2016.1142090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.